Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance, Rosaria Gangemi, Laura Paleari, Anna Maria Orengo, Alfredo Cesario, Leonardo Chessa, Silvano Ferrini, Patrizia Russo, Curr Med Chem 2009; 16(14): 1688-703 [PubMed Citation].
Targeting stem cells-clinical implications for cancer therapy, Lan C Tu, Greg Foltz, Edward Lin, Leroy Hood, Qiang Tian, Curr Stem Cell Res Ther 2009(May); 4(2): 147-53 [PubMed Citation].
TARGETING OF CANCER STEM CELL MARKER EpCAM BY BISPECIFIC ANTIBODY EpCAMxCD3 INHIBITS PANCREATIC CARCINOMA, Alexei V Salnikov and 9 co-authors, J Cell Mol Med 2009(Apr 2) [Epub ahead of print][PubMed Citation].
Number crunching in the cancer stem cell market, Malcolm R Alison, Shahriar Islam, Susan ML Lim, Breast Cancer Res 2009(Apr 24); 11(2): 302 [Epub ahead of print][PubMed Citation].
Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma, Dongho Choi, Hyo Won Lee, Kyung Yul Hur, Jae Joon Kim, Gyeong-Sin Park, Si-Hyong Jang, Young Soo Song, Ki-Seok Jang, and Seung Sam Paik, World J Gastroenterol 2009(May 14_; 15(18): 2258-64 [PubMed Citation][Full text via PMC].
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment